Shaping the future of Parkinson's care, together

Join the Remepy community and get updates, webinars, and news about our upcoming Phase III trial

Keep Me Updated:

No strings attached. We promise not to send unnecessary content

We respect your privacy; you can remove yourself from our newsletter at any time

Hybrid DrugsTM

We are developing an innovative Hybrid Drug for Parkinson's disease that combines immediate-release levodopa/carbidopa with an app-delivered therapeutic protocol.

Phase III Trial

After encouraging earlier studies, we're preparing for a Phase III clinical trial in the US

Completed
Phase I Trial
Completed
Phase II Trial
Coming Soon  2026
Phase III
Next:
Regulatory
Approval

Join Today

Join our newsletter to be the first to hear about it

I want to stay in touch

Content tailored for you

  • Useful
    Information

    Tips, tools, and insights about living with Parkinson's - body, mind, and relationships

  • Community

    Be part of a community of people living with Parkinson's, caregivers, and professionals who care

  • Research
    Updates

    News and updates about our clinical trials for Parkinson's disease

  • Webinars

    "Parkinson's, Real Talk" - conversations on topics that matter to you, with experts and community members sharing their lived experiences